SC
PMVP icon

Shay Capital’s PMV Pharmaceuticals PMVP Stock Holding History

Shay Capital’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24,310
Closed -$25.8K – 485
2025
Q2 		$25.8K Buy
+24,310
New +$23.8K ﹤0.01% 303
2025
Q1 		– Sell
-156,451
Closed -$236K – 400
2024
Q4 		$236K Sell
156,451
-31,600
-17% -$50K 0.04% 243
2024
Q3 		$280K Buy
188,051
+22,651
+14% +$35K 0.04% 225
2024
Q2 		$268K Sell
165,400
-31,778
-16% -$57.3K 0.04% 203
2024
Q1 		$335K Buy
+197,178
New +$368K 0.05% 234

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Shay Capital's PMVP Position: Q3 2025 in Review

Shay Capital sold out of PMV Pharmaceuticals (PMVP) in Q3 2025, closing a stake of 24,310 shares — an estimated $25.8K sold.

Shay Capital first reported a position in PMVP in Q1 2024 and held it in 5 quarters. The position peaked at $335K in Q1 2024. 64 funds tracked by Wall St. Rank hold PMVP as of Q3 2025.

  • Shay Capital reported no remaining PMV Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Shay Capital sold 24,310 PMV Pharmaceuticals shares in Q3 2025, an estimated $25.8K.
  • Shay Capital first reported a position in PMV Pharmaceuticals in Q1 2024 and held it in 5 quarters.
  • Shay Capital's PMV Pharmaceuticals position peaked at $335K in Q1 2024.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2025.

Based on Shay Capital's 13F filing for Q3 2025, filed 14 Nov 2025.